Treatment of Kidney Stone Disease, Benign Prostatic Hyperplasia and Chronic Prostatitis with Thermobalancing Therapy should be listed in the Guidance for Health Professionals

Abstract

The prevalence of kidney stone disease, chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) and benign prostatic hyperplasia (BPH) increases around the world. Long-term medications and surgical procedures for these non-life-threatening chronic conditions can develop serious side effects and complications. At the same time, Thermobalancing therapy (TT) with Dr Allen's therapeutic Device (DATD) has shown its high effectiveness in the treatment of chronic internal diseases. Discussion at many international conferences in 2017-2018 was aimed at treating various chronic non-malignant diseases with the help of Thermobalancing therapy, such as BPH, CP/CPPS, kidney stones and cardiovascular diseases. In the conferences were presented cases of TT with DATD of patients with kidney stone disease that confirm the ability of DATD to dissolve any type and size of kidney stone; discussed the outcomes from the clinical trials of TT in 124 men with BPH and 45 patients with CP/CPPS, before and after 6-month period they used DATD. The assured results of the cases and clinical trials reveal that TT with DATD treats the cause of kidney stone disease, CP/CPPS and BPH. Implementation of this therapy is needed today, as it helps patients avoid long-term drugs and surgical procedures, including extracorporeal shock wave lithotripsy (ESWL) with their risks and complications. In addition, it is a cost-effective solution. Therefore, conference participants proposed that TT with DATD should be included in the Guidance for health professionals.